Edinburgh et al. - Google Patents

Reproduced with permission of the COP)/fight Owner. Further reproduction prohibited without permission.

Edinburgh et al.

Document ID
3694194005836724000
Author
Edinburgh E
COUPAR J

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Soussain et al. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
US20230233579A1 (en) Anti-cancer effects of jak2 inhibitors in combination with thalidomide derivatives and glucocorticoids
Scandling et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants
Cadman et al. Clinical, biological, and biochemical effects of pyrazofurin
Bastion et al. Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
Maris et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning
Prasad et al. Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD)
US20250152575A1 (en) Methods for treating immunodeficiency disease
US20220088090A1 (en) Microbiome related immunotherapies
Rabe et al. Theophylline and airway inflammation.
JP2016518816A (en) Assays and methods for selecting treatment regimens for subjects suffering from depression
Wilson et al. Relation of vitamin C levels to mortality in a geriatric hospital: a study of the effect of vitamin C administration
Barone et al. Characterization and mechanisms of thymic atrophy in protein-malnourished mice: role of corticosterone
Marsh Functional and structural aspects of the epithelial lymphocyte, with implications for coeliac disease and tropical sprue
Reyes et al. Treatment with AM3 restores defective T-cell function in COPD patients
Baumel et al. Decreased potency of CNS depressants after prolonged social isolation in mice
Edinburgh et al. Reproduced with permission of the COP)/fight Owner. Further reproduction prohibited without permission.
Dutt et al. Smear-negative, culture-positive pulmonary tuberculosis: Six-month chemotherapy with isoniazid and rifampin
McElhaney et al. Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly
Gilman et al. Diagnosis and treatment of chronic graft-versus-host disease
Wickramasinghe et al. Macrophages are a major source of acetaldehyde in circulating acetaldehyde‐albumin complexes formed after exposure of mice to ethanol
Bril et al. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
CA2251733A1 (en) Dhea combination therapy
Suhanova et al. Toxicity profile of the new compound XC221GI from pre-clinical studies
Rivkina et al. Infliximab in graft-versus-host disease